Literature DB >> 30073350

Choroidal Vascular Reactivity in Central Serous Chorioretinopathy.

Felice Cardillo Piccolino1, Marco Lupidi1,2,3, Carlo Cagini2, Daniela Fruttini4, Massimo Nicolò1,5, Chiara Maria Eandi1,6, Silvia Tito1.   

Abstract

Purpose: To investigate by optical coherence tomography angiography (OCT-A) the choroidal vascular response to experimentally increased blood pressure in patients with central serous chorioretinopathy (CSCR).
Methods: For this multicenter, observational, case-control study, we enrolled 35 patients with an established diagnose of CSCR and 25 age-matched healthy controls. All subjects underwent a handgrip isometric exercise to obtain elevation of blood pressure (BP). In the resting phase and during the physical effort, macular OCT-angiograms were acquired. Systemic hemodynamic data were recorded at baseline and during stress conditions using an electronic sphygmomanometer. The analysis of vascular density (VD) of the choriocapillaris (CC) was performed on OCT-angiograms. The results obtained in CSCR patients, both at baseline and during the stress test, were compared with those of healthy subjects.
Results: Baseline and under stress values of systolic BP, diastolic BP, and mean arterial pressure were significantly higher (P < 0.05) in CSCR patients compared to controls, reaching values in the range of hypertension during the exercise. Baseline VD values of the CC were significantly lower (P < 0.05) in CSCR cases compared to healthy subjects. We noticed a significant increase (P < 0.05) in these values under stress condition in CSCR patients and not in controls. Conclusions: The present study suggests that choroidal blood flow is dysregulated in CSCR. During physical stress, CSCR patients easily reach critical values of BP that are not dampened by compensatory mechanisms in the choroidal vessels, as it happens in healthy subjects. The CC in CSCR could be particularly vulnerable to variations of systemic hemodynamics.

Entities:  

Mesh:

Year:  2018        PMID: 30073350     DOI: 10.1167/iovs.18-23995

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

1.  Prospective Impact of Sildenafil on Chronic cEntral Serous Chorioretinopathy: PISCES Trial.

Authors:  Mark P Breazzano; D Jackson Coleman; Royce W S Chen; Stanley Chang; Suzanne Daly; Stephen H Tsang
Journal:  Ophthalmol Retina       Date:  2020-06-07

2.  Retinal and choroidal vasoreactivity in central serous chorioretinopathy.

Authors:  Susana Penas; Teresa Araújo; Ana Maria Mendonça; Simão Faria; Jorge Silva; Aurélio Campilho; Maria Lurdes Martins; Vânia Sousa; Amândio Rocha-Sousa; Ângela Carneiro; Fernando Falcão-Reis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-15       Impact factor: 3.535

3.  Response to 'Comment on 'Drusen and pachydrusen: the definition, pathogenesis and clinical significance''.

Authors:  Xinyuan Zhang; Sobha Sivaprasad
Journal:  Eye (Lond)       Date:  2021-05-27       Impact factor: 3.775

4.  Relationship of Choroidal Vasculature and Choriocapillaris Flow With Alterations of Salivary α-Amylase Patterns in Central Serous Chorioretinopathy.

Authors:  Fabio Scarinci; Francesca Romana Patacchioli; Eliana Costanzo; Mariacristina Parravano
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.925

5.  In-vivo visualization of the photoreceptors using Spectralis High Magnification Module imaging in central serous chorioretinopathy.

Authors:  Ramkailash Gujar; Alessio Muzi; Carlo Cagini; Cesare Mariotti; Felice Cardillo Piccolino; Jay Chhablani; Marco Lupidi
Journal:  Am J Ophthalmol Case Rep       Date:  2021-12-31

6.  CENTRAL SEROUS CHORIORETINOPATHY: High-Resolution Imaging of Asymptomatic Fellow Eyes Using Adaptive Optics Scanning Laser Ophthalmoscopy.

Authors:  Melvin Gerardy; Nilufer Yesilirmak; Richard Legras; Francine Behar-Cohen; Elodie Bousquet
Journal:  Retina       Date:  2022-02-01       Impact factor: 4.256

7.  Investigation of Serum and Macular Carotenoids in Central Serous Chorioretinopathy.

Authors:  Yuying Ji; Yuhong Gan; Yongyue Su; Yining Zhang; Miaoling Li; Lan Mi; Chengguo Zuo; Feng Wen
Journal:  Front Med (Lausanne)       Date:  2022-04-01

Review 8.  Biomarkers for central serous chorioretinopathy.

Authors:  Gideon Nkrumah; Manuel Paez-Escamilla; Sumit Randhir Singh; Mohammed Abdul Rasheed; Dmitri Maltsev; Abhilash Guduru; Jay Chhablani
Journal:  Ther Adv Ophthalmol       Date:  2020-08-24

Review 9.  Applications of Multimodal Imaging in Central Serous Chorioretinopathy Evaluation.

Authors:  Mary Ho; Gabriel Li; Andrew Mak; Danny Ng; Lawrence Iu; Frank Lai
Journal:  J Ophthalmol       Date:  2021-07-24       Impact factor: 1.909

10.  Short-Term Outcomes of Cataract Surgery in Patients with a History of Central Serous Chorioretinopathy.

Authors:  Jeon Young Joon; Jae Hui Kim; Jong Woo Kim; Chul Gu Kim
Journal:  J Ophthalmol       Date:  2021-06-24       Impact factor: 1.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.